MILAN, ITALY — Amplifon has announced the successful placement of €600 million (~$690 million USD) in bonds, securing additional financing for its planned acquisition of GN Hearing’s hearing aid business. The five-year bond offering, which matures in 2031, attracted substantial interest from European institutional investors. According to Amplifon, demand at its peak exceeded five times the amount of bonds offered....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate finance event with no direct implication for clinical practice.
If completed, Amplifon's acquisition of GN Hearing would further consolidate the global hearing aid industry, potentially reshaping brand availability, pricing, and dispensing relationships for independent clinics.
- 01Amplifon issued a €600 million (~$690M USD) five-year bond maturing in 2031.
- 02Proceeds are earmarked to help finance the planned acquisition of GN Hearing's hearing aid business.
- 03The deal would combine one of the largest retail hearing care networks with a major hearing aid manufacturer.
- 04Increased vertical integration could affect independent dispensers' access to GN/ReSound products.
- 05No clinical or product changes have been announced in connection with this financing.
Amplifon completed a €600 million bond offering maturing in 2031 to help fund the GN Hearing acquisition.
press releasesupported